🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today we stand with the World Health Organization (WHO) & public health champions around the world to celebrate World No Tobacco Day (#WNTD). Smoking increases risk of all types of cancer, including all digestive cancers. Don’t let Tobacco take your life away. DON’T SMOKE! #EWAC2023 #WorldNoTobaccoDay2023

We're counting down the days to this year's UCD Festival! Hope we'll see you and your family on Saturday, June 10, at UCD! It's going to be a great day. #UCDFestival2023 #free #Dublin #freeactivitiesforkids #science #handson

Call 3 Now Open! #PrecisionOncology #Fellowship opportunities. Our programme is led by Systems Biology Ire with fellows based in universities across Ireland. For more information, please visit: ucd.ie/developmed/

📣 Join DiCE's focus group & contribute to our mission of raising awareness about the increasing incidence of colorectal cancer in young Europeans. If you are: 🔹 Over 18? 🔹Diagnosed with #CRC before 50? 🔹Willing to share? Get in touch: [email protected]

Pan-KRAS, non-covalent, small molecule inhibitor not discriminating between KRAS mutants. The time has arrived! #lcsm nature.com/articles/s4158…

Where your #ColorectalCancer first began matters. Not all #ColonCancers are the same. Knowing which side of the colon it originated can give you insight into your symptoms, impact how you heal post-surgery, & affect your treatment plan. Learn more: bit.ly/3qvmVJm #ASCO23

Our team would love to meet you at #BIO2023! Schedule a meeting with our Biopharma Services team to discuss how we can work together to help advance #precisionmedicine in the era of #immunooncology and combination therapies.

DYK: COLOSSUS was the highest-ranked application from more than 200 European🇪🇺 projects submitted under a #Horizon2020 #PersonalizedMedicine Call?

Exciting new Postdoc role in SBI, supporting research activity on a clinical study focusing on molecular & genomic interrogation of childhood cancer. Check out link for more info ⤵️ #researchcareers #jobfairy #cancerresearch CHI at Crumlin UCD Medicine ucd.ie/sbi/news/jobs/

Study of DSP107 Alone and in Combination With Atezolizumab for Patients With Advanced Solid Tumors #ASCO23 abstract Anwaar Saeed Jason Luke, MD, FACP responses in KRAS & BRAF Colorectal Cancer patients meetings.asco.org/abstracts-pres… poster on KAHR Bio website kahrbio.com/wp-content/upl…

Results from international clinical trial published The Lancet 15/6 show that the selective targeted therapy Fruquintinib resulted in a statistically significant improvement in overall survival and progression-free survival for those w #colorectalcancer. news-medical.net/news/20230616/…

Indeed it is! Thank you for drawing more attention here.

Today, our project officially ends. Thanks to all of you that we met and worked with here and in other ways. As we continue to publish and analyse results, keep an eye on our website for news. 🇪🇺Horizon Europe 🇪🇺

Help needed 📢 Have you had #ColorectalCanceror are you living with an increased risk of developing it? Would you like to join an awesome group and help shape relevant research, and consequently, earlier diagnoses and better outcomes? Check it out 👇🤓 #CancerResearch #PPI

La #nanomedicina per eliminare la terapia antirigetto con il progetto Phoenix Horizon Europe Horizon Europe 🇪🇺 🇪🇺 fondazionetrapiantionlus.org/?p=1453

Our latest publication in Bioinformatics from Università di Torino: CONNECTOR, fitting and clustering of longitudinal data to reveal a new risk stratification system pubmed.ncbi.nlm.nih.gov/37079732/

Cardiff Oncology Launches New Phase II Trial in RAS-Mutated Colorectal Cancer. Following results from a Phase II trial in second-line KRAS-mutated colorectal cancer, Cardiff is discontinuing that program and pivoting to first-line RAS mutated disease. ow.ly/UnUH104QAVw

New paper today in Cancers MDPI from the Gomez-Matallanas Group, first author Aoife Nolan! Fascinating continuation of the group's work on RAS mutations & how greater understanding can potentially improve cancer treatment. COLOSSUS UCD Conway Institute Edinburgh Cancer Research mdpi.com/2072-6694/15/1…